comparemela.com

Latest Breaking News On - Rsls - Page 3 : comparemela.com

Head-To-Head Contrast: ReShape Lifesciences (OTCMKTS:RSLS) vs Sigyn Therapeutics (OTCMKTS:SIGY)

ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and Sigyn Therapeutics (OTCMKTS:SIGY – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and valuation. Earnings & Valuation This table compares ReShape Lifesciences and […]

ReShape Lifesciences (OTCMKTS:RSLS) Stock Price Passes Above 200 Day Moving Average of $3 17

ReShape Lifesciences Inc. (OTCMKTS:RSLS – Get Rating)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $3.17 and traded as high as $4.10. ReShape Lifesciences shares last traded at $3.13, with a volume of 3,839,948 shares traded. ReShape Lifesciences Stock Down 1.0 % […]

Financial Analysis: OrthoPediatrics (NASDAQ:KIDS) and ReShape Lifesciences (OTCMKTS:RSLS)

ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Analyst Recommendations This is a breakdown of current recommendations and […]

ReShape Lifesciences (OTCMKTS:RSLS) Stock Price Passes Above 200 Day Moving Average of $2 84

Shares of ReShape Lifesciences Inc. (OTCMKTS:RSLS – Get Rating) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.84 and traded as high as $3.34. ReShape Lifesciences shares last traded at $3.02, with a volume of 105,093 shares. ReShape Lifesciences Trading […]

ReShape Lifesciences Inc (OTCMKTS:RSLS) CEO Sells $10,743 55 in Stock

ReShape Lifesciences Inc. (OTCMKTS:RSLS – Get Rating) CEO Barton P. Bandy sold 11,309 shares of the business’s stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $0.95, for a total transaction of $10,743.55. Following the transaction, the chief executive officer now owns 796,214 shares of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.